Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of progesterone and estrogen receptors and low (or absent) HER2 expression. TNBC accounts for 15-20% of all breast cancers. It is associated with younger age, a higher mutational burden, and a...
Saved in:
| Main Authors: | Lucía Serrano García, Beatriz Jávega, Antonio Llombart Cussac, María Gión, José Manuel Pérez-García, Javier Cortés, María Leonor Fernández-Murga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1513421/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study
by: Rebecca Dent, et al.
Published: (2025-03-01) -
Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial
by: Elena López-Miranda, et al.
Published: (2025-08-01) -
The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer
by: Xinhai Gao, et al.
Published: (2025-05-01) -
Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01) -
ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
by: Hae-Yun Jung, et al.
Published: (2023-12-01)